|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/4725 | |
| A61K 31/4178 | |||
| A61K 31/55 | |||
| A61P 31/12 | |||
| A61P 31/14 |
| (11) | Number of the document | 2600835 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11815206.5 |
| Date of filing the European patent application | 2011-08-02 | |
| (97) | Date of publication of the European application | 2013-06-12 |
| (45) | Date of publication and mention of the grant of the patent | 2018-05-30 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/046285 |
| Date | 2011-08-02 |
| (87) | Number | WO 2012/018829 |
| Date | 2012-02-09 |
| (30) | Number | Date | Country code |
| 371399 P | 2010-08-06 | US |
| (72) |
GAO, Min, US
GARDINER, David F., US
LEMM, Julie A., US
MCPHEE, Fiona, US
VOSS, Stacey A., US
|
| (73) |
Bristol-Myers Squibb Holdings Ireland,
Hinterbergstrasse 16, 6312 Steinhausen,
CH
|
| (54) | COMBINATIONS OF HEPATITIS C VIRUS INHIBITORS |
| COMBINATIONS OF HEPATITIS C VIRUS INHIBITORS |